A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes.
暂无分享,去创建一个
Teruhiko Yoshida | A. Shimomura | K. Yonemori | Y. Fujiwara | K. Tamura | N. Masuda | Masato Takahashi | K. Aogi | A. Hirakawa | H. Michimae | A. Hamada | J. Hashimoto | H. Yasojima | Y. Naito | R. Nakamura | Harukaze Yamamoto | S. Shimizu | T. Sukigara | M. Takahashi | H. Yamamoto